Covid and beyond: Perspectives on how Cochrane can respond to the needs of users

Wednesday, 21st April 2021, 2:00pm-3:30pm

What are the needs of Cochrane stakeholders to respond to global health crises?

Cochrane’s response to the COVID-19 pandemic in 2020 focused on relevant questions that informed healthcare decision-making and built on methods and quality processes established by Cochrane over the years. Stakeholders’ needs were at the heart of our successful response, and the need for high-quality evidence synthesis was paramount. In planning our continued response, there is an opportunity to reflect on how systematic reviews should be produced in the future. Do stakeholders need different types of reviews and novel ways of synthesizing diverse evidence? How can we unleash the potential of the data and syntheses produced in Cochrane Reviews to support future responses to global crises?

This session will focus on the needs of policy-makers, consumers, funders, and producers of evidence. Four panellists will be asked to discuss their views on Cochrane’s role in future response to global health crises, how systematic reviews should evolve to respond to stakeholders needs, what values Cochrane brings, and the potential challenges going forward.

Panel

Karla Soares-Weiser

Editor in Chief, Cochrane Library 


.

.

.

.

.

.

John Grove

John Grove

Director of Quality Assurance for Norms & Standards, World Health Organization


.

.

.

Declan Devane 

Director of Evidence Synthesis Ireland and Director of Cochrane Ireland


Maureen Smith

Chair of Cochrane’s Consumer Executive


Read Maureen's biography here

.

.

Lisa Bero

Professor of Medicine and Public Health and Chief Scientist at the Center for Bioethics and Humanities, University of Colorado and Senior Editor, Research Integrity and Public Health and Health Systems Network, Cochrane


.
.

.Ken Stein

Director of the National Insitute for Health Research (NIHR) Evidence Synthesis Programme


Read Ken's biography here